Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics — Michael L. Lovett (2015) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics
DK
Shared by
David Kaplan
Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics
Article
2015
en
Authors
+4 more
ML
Michael L. Lovett
XW
Xiaoqin Wang
TY
Tuna Yücel
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2014
Silk fibroin rods for sustained delivery of breast cancer therapeutics
Tuna Yücel
,
Michael L. Lovett
,
Raffaella Giangregorio
,
Erin Coonahan
,
David Kaplan
Article
2004
Mechanisms of disease: angiogenesis, vascular endothelial growth factor (VEGF) and psoriasis
Christopher Em Griffiths
,
Helen Young
,
Angela Summers
,
Paul Brenchley
Article
2004
Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration
Ludo Van Den Bosch
,
Erik Storkebaum
,
V. Vleminckx
,
Lieve Moons
,
Ludo Vanopdenbosch
,
Wendy Scheveneels
,
Peter Carmeliet
,
Wim Robberecht
Article
2003
The effect of Vascular Endothelial Growth Factor (VEGF) on Motoneuron Degeneration
Ludo Van Den Bosch
,
Erik Storkebaum
,
V. Vleminckx
,
Lieve Moons
,
Ludo Vanopdenbosch
,
Wendy Scheveneels
,
Peter Carmeliet
,
Marc M. Van Hulle
,
Wim Robberecht
Article
2002
Vascular Endothelial Growth Factor (VEGF) in Ankylosing Spondylitis - a Pilot Study
C Goldberger
,
Jozef Dulak
,
Christina Duftner
,
Franz Weidinger
,
A. Falkenbach
,
Michael Schirmer
Discussion(0)
No comments yet. Be the first to comment.